BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23987099)

  • 1. A novel helper-dependent adenovirus-based cell culture model for Hepatitis C virus replication and production.
    Zhou X; Zeng Y; Li J; Guo Y; Fu Y; He J; Sun S; Zhou Y
    Virol J; 2013 Aug; 10():273. PubMed ID: 23987099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of hepatitis C virus production reporter-assay systems using two different hepatoma cell lines.
    Takeda M; Ikeda M; Ariumi Y; Wakita T; Kato N
    J Gen Virol; 2012 Jul; 93(Pt 7):1422-1431. PubMed ID: 22456614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
    Eyre NS; Phillips RJ; Bowden S; Yip E; Dewar B; Locarnini SA; Beard MR
    J Hepatol; 2009 Sep; 51(3):446-57. PubMed ID: 19596477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired antiviral activity of interferon alpha against hepatitis C virus 2a in Huh-7 cells with a defective Jak-Stat pathway.
    Hazari S; Chandra PK; Poat B; Datta S; Garry RF; Foster TP; Kousoulas G; Wakita T; Dash S
    Virol J; 2010 Feb; 7():36. PubMed ID: 20149251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient production of infectious hepatitis C virus with adaptive mutations in cultured hepatoma cells.
    Bungyoku Y; Shoji I; Makine T; Adachi T; Hayashida K; Nagano-Fujii M; Ide YH; Deng L; Hotta H
    J Gen Virol; 2009 Jul; 90(Pt 7):1681-1691. PubMed ID: 19282429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermostable hepatitis C virus JFH1-derived variant isolated by adaptation to Huh7.5.1 cells.
    Shirasago Y; Fukazawa H; Aizaki H; Suzuki T; Suzuki T; Sugiyama K; Wakita T; Hanada K; Abe R; Fukasawa M
    J Gen Virol; 2018 Oct; 99(10):1407-1417. PubMed ID: 30045785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype 1a HCV (H77S) infection system.
    Yi M; Lemon SM
    Methods Mol Biol; 2009; 510():337-46. PubMed ID: 19009273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino Acid Mutations in the NS4A Region of Hepatitis C Virus Contribute to Viral Replication and Infectious Virus Production.
    Murayama A; Sugiyama N; Suzuki R; Moriyama M; Nakamura N; Mochizuki H; Wakita T; Kato T
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication of a hepatitis C virus replicon clone in mouse cells.
    Uprichard SL; Chung J; Chisari FV; Wakita T
    Virol J; 2006 Oct; 3():89. PubMed ID: 17069661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-derived hepatitis C virus and JFH-1 clones differ in their ability to infect human hepatoma cells and lymphocytes.
    Sarhan MA; Chen AY; Russell RS; Michalak TI
    J Gen Virol; 2012 Nov; 93(Pt 11):2399-2407. PubMed ID: 22855787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of an Huh.7.5.1-derived cell clone highly permissive to hepatitis C virus.
    Shirasago Y; Sekizuka T; Saito K; Suzuki T; Wakita T; Hanada K; Kuroda M; Abe R; Fukasawa M
    Jpn J Infect Dis; 2015; 68(2):81-8. PubMed ID: 25420655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors.
    Sargent KL; Ng P; Evelegh C; Graham FL; Parks RJ
    Gene Ther; 2004 Mar; 11(6):504-11. PubMed ID: 14999222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracytoplasmic stable expression of IgG1 antibody targeting NS3 helicase inhibits replication of highly efficient hepatitis C Virus 2a clone.
    Chandra PK; Hazari S; Poat B; Gunduz F; Prabhu R; Liu G; Burioni R; Clementi M; Garry RF; Dash S
    Virol J; 2010 Jun; 7():118. PubMed ID: 20529250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient trans-encapsidation of hepatitis C virus RNAs into infectious virus-like particles.
    Steinmann E; Brohm C; Kallis S; Bartenschlager R; Pietschmann T
    J Virol; 2008 Jul; 82(14):7034-46. PubMed ID: 18480457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of Replication-Competent HCV Strain with Minimum Modifications.
    Kato T; Murayama A; Wakita T
    Methods Mol Biol; 2019; 1911():73-83. PubMed ID: 30593618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intragenotypic JFH1 based recombinant hepatitis C virus produces high levels of infectious particles but causes increased cell death.
    Mateu G; Donis RO; Wakita T; Bukh J; Grakoui A
    Virology; 2008 Jul; 376(2):397-407. PubMed ID: 18455749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host.
    Sa-Ngiamsuntorn K; Wongkajornsilp A; Phanthong P; Borwornpinyo S; Kitiyanant N; Chantratita W; Hongeng S
    Virol J; 2016 Apr; 13():59. PubMed ID: 27044429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HCV replication in Huh-7.5 cell line].
    Komorowski M; Kołakowska A; Godzik P; Madaliński K
    Med Dosw Mikrobiol; 2012; 64(3):239-44. PubMed ID: 23285778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell culture replication of a genotype 1b hepatitis C virus isolate cloned from a patient who underwent liver transplantation.
    Koutsoudakis G; Perez-del-Pulgar S; Coto-Llerena M; Gonzalez P; Dragun J; Mensa L; Crespo G; Navasa M; Forns X
    PLoS One; 2011; 6(8):e23587. PubMed ID: 21887279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-mediated gene transfer of interferon alpha inhibits hepatitis C virus replication in hepatocytes.
    Suzuki K; Aoki K; Ohnami S; Yoshida K; Kazui T; Kato N; Inoue K; Kohara M; Yoshida T
    Biochem Biophys Res Commun; 2003 Aug; 307(4):814-9. PubMed ID: 12878183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.